154 related articles for article (PubMed ID: 37353671)
1. Core Shell Lipid-Polymer Hybrid Nanoparticles for Oral Bioavailability Enhancement of Ibrutinib via Lymphatic Uptake.
Patel M; Desai A; Kansara V; Vyas B
AAPS PharmSciTech; 2023 Jun; 24(6):142. PubMed ID: 37353671
[TBL] [Abstract][Full Text] [Related]
2. Investigating the effectiveness of Difluprednate-Loaded core-shell lipid-polymeric hybrid nanoparticles for ocular delivery.
Kaviarasi B; Rajana N; Pooja YS; Rajalakshmi AN; Singh SB; Mehra NK
Int J Pharm; 2023 Jun; 640():123006. PubMed ID: 37137420
[TBL] [Abstract][Full Text] [Related]
3. Development and
Yousaf R; Khan MI; Akhtar MF; Madni A; Sohail MF; Saleem A; Irshad K; Sharif A; Rana M
Heliyon; 2023 Mar; 9(3):e14281. PubMed ID: 36925532
[TBL] [Abstract][Full Text] [Related]
4. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery.
Tahir N; Madni A; Li W; Correia A; Khan MM; Rahim MA; Santos HA
Int J Pharm; 2020 May; 581():119275. PubMed ID: 32229283
[TBL] [Abstract][Full Text] [Related]
5. Development and In Vitro Evaluation of Crizotinib-Loaded Lipid-Polymer Hybrid Nanoparticles Using Box-Behnken Design in Non-small Cell Lung Cancer.
Korucu Aktas P; Baysal I; Yabanoglu-Ciftci S; Arica B
AAPS PharmSciTech; 2023 Sep; 24(7):178. PubMed ID: 37658977
[TBL] [Abstract][Full Text] [Related]
6. Stealth lipid polymer hybrid nanoparticles loaded with rutin for effective brain delivery - comparative study with the gold standard (Tween 80): optimization, characterization and biodistribution.
Ishak RAH; Mostafa NM; Kamel AO
Drug Deliv; 2017 Nov; 24(1):1874-1890. PubMed ID: 29191047
[TBL] [Abstract][Full Text] [Related]
7. Exploring Peyer's Patch Uptake as a Strategy for Targeted Lung Delivery of Polymeric Rifampicin Nanoparticles.
Bachhav SS; Dighe VD; Devarajan PV
Mol Pharm; 2018 Oct; 15(10):4434-4445. PubMed ID: 30106591
[TBL] [Abstract][Full Text] [Related]
8. Lipid poly (ɛ-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy.
Khan S; Aamir MN; Madni A; Jan N; Khan A; Jabar A; Shah H; Rahim MA; Ali A
Life Sci; 2021 Nov; 284():119909. PubMed ID: 34450169
[TBL] [Abstract][Full Text] [Related]
9. [Effects of shell composition in shell-core structured nanoparticles on oral physiological barrier and bioavailability].
Chen HZ; Shi JP; Gu XY; Peng YZ; Gao YZ; Liu Y; Feng NP
Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3475-3480. PubMed ID: 35850798
[TBL] [Abstract][Full Text] [Related]
10. EGF-functionalized lipid-polymer hybrid nanoparticles of 5-fluorouracil and sulforaphane with enhanced bioavailability and anticancer activity against colon carcinoma.
Li S; Xu Z; Alrobaian M; Afzal O; Kazmi I; Almalki WH; Altamimi ASA; Al-Abbasi FA; Alharbi KS; Altowayan WM; Singh T; Akhter MH; Gupta M; Rahman M; Beg S
Biotechnol Appl Biochem; 2022 Oct; 69(5):2205-2221. PubMed ID: 34775646
[TBL] [Abstract][Full Text] [Related]
11. Harnessing Lipid Polymer Hybrid Nanoparticles for Enhanced Oral Bioavailability of Thymoquinone: In Vitro and In Vivo Assessments.
Imam SS; Gilani SJ; Bin Jumah MN; Rizwanullah M; Zafar A; Ahmed MM; Alshehri S
Polymers (Basel); 2022 Sep; 14(18):. PubMed ID: 36145851
[TBL] [Abstract][Full Text] [Related]
12. QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach.
Rangaraj N; Pailla SR; Shah S; Prajapati S; Sampathi S
Drug Deliv Transl Res; 2020 Oct; 10(5):1476-1494. PubMed ID: 32519202
[TBL] [Abstract][Full Text] [Related]
13. Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes.
Garg NK; Tyagi RK; Sharma G; Jain A; Singh B; Jain S; Katare OP
Mol Pharm; 2017 Jun; 14(6):1883-1897. PubMed ID: 28402673
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer.
Jain A; Sharma G; Kushwah V; Garg NK; Kesharwani P; Ghoshal G; Singh B; Shivhare US; Jain S; Katare OP
Nanomedicine (Lond); 2017 Aug; 12(15):1851-1872. PubMed ID: 28703643
[TBL] [Abstract][Full Text] [Related]
15. Development of Sustained Release Baricitinib Loaded Lipid-Polymer Hybrid Nanoparticles with Improved Oral Bioavailability.
Anwer MK; Ali EA; Iqbal M; Ahmed MM; Aldawsari MF; Saqr AA; Ansari MN; Aboudzadeh MA
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011397
[TBL] [Abstract][Full Text] [Related]
16. Rifampicin Lipid-Polymer hybrid nanoparticles (LIPOMER) for enhanced Peyer's patch uptake.
Bachhav SS; Dighe VD; Kotak D; Devarajan PV
Int J Pharm; 2017 Oct; 532(1):612-622. PubMed ID: 28935258
[TBL] [Abstract][Full Text] [Related]
17. Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy.
Tahir N; Madni A; Correia A; Rehman M; Balasubramanian V; Khan MM; Santos HA
Int J Nanomedicine; 2019; 14():4961-4974. PubMed ID: 31308666
[No Abstract] [Full Text] [Related]
18. Bioavailability enhancement and pharmacokinetic profile of an anticancer drug ibrutinib by self-nanoemulsifying drug delivery system.
Shakeel F; Iqbal M; Ezzeldin E
J Pharm Pharmacol; 2016 Jun; 68(6):772-80. PubMed ID: 27018771
[TBL] [Abstract][Full Text] [Related]
19. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.
Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S
Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
